GSK Pharma India Gets CDSCO Panel Nod for phase 3 CT of Belrestotug and Dostarlimab Dr. Divya Colin26 July 2024 6:00 PM ISTNew Delhi: The drug major GSK Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
GSK gets CDSCO Panel Nod To study Anti-cancer Drug Belantamab mafodotin Dr. Divya Colin25 Feb 2024 6:00 PM ISTNew Delhi: The drug major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
OPPI names Anil Matai as Director General Ruchika Sharma17 Oct 2023 11:49 AM ISTAnil has functioned on the boards of Zydus Healthcare, Bayer Zydus Pharma, Novartis Healthcare and Biochem Pharmaceutical Industries.
